mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.2 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.2 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
0.038 |
0.2 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.038 |
0.2 |